Xu Feng, Luo Man, He Lulu, Cao Yuan, Li Wen, Ying Songmin, Chen Zhihua, Shen Huahao
Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
State Key Laboratory of Respiratory Disease, Guangzhou, China.
Cell Physiol Biochem. 2018;46(2):699-712. doi: 10.1159/000488726. Epub 2018 Mar 29.
BACKGROUND/AIMS: Necroptosis, a form of programmed necrosis, is involved in the pathologic process of several kinds of pulmonary diseases. However, the role of necroptosis in particulate matter (PM)-induced pulmonary injury remains unclear. The objective of this study is to investigate the involvement of necroptosis in the pathogenesis of PM-induced toxic effects in pulmonary inflammation and mucus hyperproduction, both in vitro and in vivo.
PM was administered into human bronchial epithelial (HBE) cells or mouse airways, and the inflammatory response and mucus production were assessed. The mRNA expressions of IL6, IL8 and MUC5AC in HBE cells and Cxcl1, Cxcl2, and Gm-csf in the lung tissues were detected by quantitative real-time RT-PCR. The secreted protein levels of IL6 and IL8 in culture supernatants and Cxcl1, Cxcl2, and Gm-csf in bronchoalveolar lavage fluid (BALF) were detected by enzyme-linked immunosorbent assay (ELISA). We used Western blot to measure the protein expressions of necroptosis-related proteins (RIPK1, RIPK3, and Phospho-MLKL), NF-κB (P65 and PP65), AP-1 (P-c-Jun and P-c-Fos) and MUC5AC. Cell necrosis and mitochondrial ROS were detected using flow cytometry. In addition, pathological changes and scoring of lung tissue samples were monitored using hemoxylin and eosin (H&E), periodic acid-schiff (PAS) and immunohistochemistry staining.
Our study showed that PM exposure induced RIP and MLKL-dependent necroptosis in HBE cells and in mouse lungs. Managing the necroptosis inhibitor Necrostatin-1 (Nec-1) and GSK'872, specific molecule inhibitors of necroptosis, markedly reduced PM-induced inflammatory cytokines, e.g., IL6 and IL8, and MUC5AC in HBE cells. Similarly, administering Nec-1 significantly reduced airway inflammation and mucus hyperproduction in PM-exposed mice. Mechanistically, we found PM-induced necroptosis was mediated by mitochondrial reactive oxygen species-dependent early growth response gene 1, which ultimately promoted inflammation and mucin expression through nuclear factor κB and activator protein-1 pathways, respectively.
Our results demonstrate that necroptosis is involved in the pathogenesis of PM-induced pulmonary inflammation and mucus hyperproduction, and suggests that it may be a novel target for treatment of airway disorders or disease exacerbations with airborne particulate pollution.
背景/目的:坏死性凋亡是程序性坏死的一种形式,参与多种肺部疾病的病理过程。然而,坏死性凋亡在颗粒物(PM)诱导的肺损伤中的作用仍不清楚。本研究的目的是在体外和体内研究坏死性凋亡在PM诱导的肺部炎症和黏液高分泌毒性作用发病机制中的作用。
将PM作用于人支气管上皮(HBE)细胞或小鼠气道,并评估炎症反应和黏液产生。通过定量实时RT-PCR检测HBE细胞中IL6、IL8和MUC5AC以及肺组织中Cxcl1、Cxcl2和Gm-csf的mRNA表达。通过酶联免疫吸附测定(ELISA)检测培养上清液中IL6和IL8以及支气管肺泡灌洗液(BALF)中Cxcl1、Cxcl2和Gm-csf的分泌蛋白水平。我们使用蛋白质免疫印迹法检测坏死性凋亡相关蛋白(RIPK1、RIPK3和磷酸化MLKL)、NF-κB(P65和PP65)、AP-1(磷酸化c-Jun和磷酸化c-Fos)和MUC5AC的蛋白表达。使用流式细胞术检测细胞坏死和线粒体活性氧。此外,使用苏木精和伊红(H&E)、过碘酸希夫(PAS)和免疫组织化学染色监测肺组织样本的病理变化和评分。
我们的研究表明,暴露于PM可诱导HBE细胞和小鼠肺组织中RIP和MLKL依赖性坏死性凋亡。使用坏死性凋亡抑制剂Necrostatin-1(Nec-1)和坏死性凋亡特异性分子抑制剂GSK'872可显著降低PM诱导的HBE细胞中炎性细胞因子,如IL6和IL8,以及MUC5AC。同样,给予Nec-1可显著减轻PM暴露小鼠的气道炎症和黏液高分泌。机制上,我们发现PM诱导的坏死性凋亡由线粒体活性氧依赖性早期生长反应基因1介导,该基因最终分别通过核因子κB和活化蛋白-1途径促进炎症和黏蛋白表达。
我们的结果表明坏死性凋亡参与PM诱导的肺部炎症和黏液高分泌的发病机制,并提示其可能是治疗空气颗粒物污染引起的气道疾病或疾病加重的新靶点。